Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Laboratory Medicine
|
September 29, 2023
Designer drugs
Amadeo J Pesce, Kevin Krock
MLO: Medical Laboratory Observer
|
May 8, 2010
Used equipment choices
Amadeo J Pesce, Ed Tirakis
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 18, 2003
Reference intervals: an update
Paul S Horn, Amadeo J Pesce
Clinical Chemistry
|
September 27, 2002
Effect of ethnicity on reference intervals
Paul S Horn, Amadeo J Pesce
Journal of Opioid Management
|
July 30, 2025
Urinary metabolic ratio of pain management and substance abuse treatment drugs: Drug-drug interactions
Agnes Cua, Eugene Wickett, Amadeo J Pesce
Drug Testing and Analysis
|
December 27, 2016
A sensitive assay for urinary cocaine metabolite benzoylecgonine shows more positive results and longer half-lives than those using traditional cut-offs
Joyce Nickley, Amadeo J Pesce, Kevin Krock
Journal of Opioid Management
|
July 30, 2025
Urinary metabolic ratio of pain management and substance abuse treatment drugs: Reference intervals
Amadeo J Pesce, Agnes Cua, Eugene Wickett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 10, 2012
Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety
Charles Mikel, Amadeo J Pesce, Murray Rosenthal, et al.
Journal of Opioid Management
|
March 20, 2010
Variability of transdermal fentanyl metabolism and excretion in pain patients
Joanna M Cole, Brookie M Best, Amadeo J Pesce
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 1, 2001
Urine drug screening in the medical setting
Catherine A Hammett-Stabler, Amadeo J Pesce, Donald J Cannon
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Laboratory Medicine
|
September 29, 2023
Designer drugs
Amadeo J Pesce, Kevin Krock
MLO: Medical Laboratory Observer
|
May 8, 2010
Used equipment choices
Amadeo J Pesce, Ed Tirakis
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
July 18, 2003
Reference intervals: an update
Paul S Horn, Amadeo J Pesce
Clinical Chemistry
|
September 27, 2002
Effect of ethnicity on reference intervals
Paul S Horn, Amadeo J Pesce
Journal of Opioid Management
|
July 30, 2025
Urinary metabolic ratio of pain management and substance abuse treatment drugs: Drug-drug interactions
Agnes Cua, Eugene Wickett, Amadeo J Pesce
Drug Testing and Analysis
|
December 27, 2016
A sensitive assay for urinary cocaine metabolite benzoylecgonine shows more positive results and longer half-lives than those using traditional cut-offs
Joyce Nickley, Amadeo J Pesce, Kevin Krock
Journal of Opioid Management
|
July 30, 2025
Urinary metabolic ratio of pain management and substance abuse treatment drugs: Reference intervals
Amadeo J Pesce, Agnes Cua, Eugene Wickett
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
April 10, 2012
Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety
Charles Mikel, Amadeo J Pesce, Murray Rosenthal, et al.
Journal of Opioid Management
|
March 20, 2010
Variability of transdermal fentanyl metabolism and excretion in pain patients
Joanna M Cole, Brookie M Best, Amadeo J Pesce
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
December 1, 2001
Urine drug screening in the medical setting
Catherine A Hammett-Stabler, Amadeo J Pesce, Donald J Cannon
Page
of 3